pentosidine has been researched along with Metabolic Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amano, N; Arai, M; Arinami, T; Fukumoto, M; Hashimoto, R; Itokawa, M; Kasai, K; Koike, S; Kushima, I; Miyashita, M; Miyata, T; Niizato, K; Okazaki, Y; Oshima, K; Ozaki, N; Takeda, M; Toyota, T; Ujike, H; Yoshikawa, T; Yuzawa, H | 1 |
1 other study(ies) available for pentosidine and Metabolic Diseases
| Article | Year |
|---|---|
Replication of enhanced carbonyl stress in a subpopulation of schizophrenia.
Topics: Arginine; Biomarkers; Case-Control Studies; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Metabolic Diseases; Pyridoxal; Schizophrenia; Stress, Physiological | 2014 |